DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $8,156,123 | -5.9% | 35,256 | +0.9% | 1.40% | -17.6% |
| Q3 2023 | $8,670,847 | -0.2% | 34,949 | -3.5% | 1.70% | +16.1% |
| Q2 2023 | $8,692,080 | -5.1% | 36,217 | -0.3% | 1.47% | -10.1% |
| Q1 2023 | $9,155,101 | +95077.3% | 36,324 | +0.2% | 1.63% | -10.1% |
| Q4 2022 | $9,619 | -99.9% | 36,239 | -0.5% | 1.82% | -0.5% |
| Q3 2022 | $9,407,000 | +2.1% | 36,420 | +0.2% | 1.83% | +13.0% |
| Q2 2022 | $9,211,000 | -13.8% | 36,332 | -0.2% | 1.62% | -1.5% |
| Q1 2022 | $10,683,000 | -12.1% | 36,420 | -1.4% | 1.64% | -9.6% |
| Q4 2021 | $12,155,000 | +7.9% | 36,946 | -0.1% | 1.82% | -1.3% |
| Q3 2021 | $11,260,000 | +12.0% | 36,987 | -1.3% | 1.84% | +8.5% |
| Q2 2021 | $10,055,000 | +19.2% | 37,468 | -0.0% | 1.70% | +11.4% |
| Q1 2021 | $8,437,000 | -0.8% | 37,483 | -2.1% | 1.52% | -7.8% |
| Q4 2020 | $8,503,000 | +11.7% | 38,277 | +8.3% | 1.65% | -3.1% |
| Q3 2020 | $7,609,000 | +21.0% | 35,334 | -0.6% | 1.70% | +13.9% |
| Q2 2020 | $6,288,000 | +27.8% | 35,559 | -0.0% | 1.49% | +10.2% |
| Q1 2020 | $4,922,000 | -8.5% | 35,565 | +1.5% | 1.36% | +8.1% |
| Q4 2019 | $5,379,000 | +5.6% | 35,045 | -0.7% | 1.25% | +1.0% |
| Q3 2019 | $5,096,000 | -0.0% | 35,287 | -1.1% | 1.24% | -2.6% |
| Q2 2019 | $5,098,000 | +8.3% | 35,669 | +0.0% | 1.28% | +6.0% |
| Q1 2019 | $4,707,000 | +25.1% | 35,653 | -2.3% | 1.20% | +14.2% |
| Q4 2018 | $3,762,000 | -5.5% | 36,479 | -0.4% | 1.05% | +3.7% |
| Q3 2018 | $3,981,000 | +11.0% | 36,640 | +0.8% | 1.02% | +5.9% |
| Q2 2018 | $3,586,000 | -0.9% | 36,346 | -1.7% | 0.96% | +0.3% |
| Q1 2018 | $3,619,000 | +6.0% | 36,963 | +0.5% | 0.96% | +12.6% |
| Q4 2017 | $3,413,000 | +7.5% | 36,767 | -0.6% | 0.85% | +5.2% |
| Q3 2017 | $3,174,000 | +1.5% | 37,002 | -0.2% | 0.81% | -0.4% |
| Q2 2017 | $3,128,000 | -2.9% | 37,068 | -1.5% | 0.81% | -8.1% |
| Q1 2017 | $3,220,000 | +11.9% | 37,641 | +1.8% | 0.88% | +9.2% |
| Q4 2016 | $2,878,000 | +1.0% | 36,968 | +1.7% | 0.81% | -1.0% |
| Q3 2016 | $2,850,000 | -21.9% | 36,357 | +0.6% | 0.81% | -22.5% |
| Q2 2016 | $3,650,000 | +7.6% | 36,133 | +1.1% | 1.05% | +3.1% |
| Q1 2016 | $3,391,000 | +3.6% | 35,742 | +1.4% | 1.02% | +1.5% |
| Q4 2015 | $3,274,000 | +8.7% | 35,248 | -0.3% | 1.00% | +4.9% |
| Q3 2015 | $3,011,000 | -1.0% | 35,337 | -0.5% | 0.96% | +7.9% |
| Q2 2015 | $3,041,000 | +3.3% | 35,532 | +2.5% | 0.89% | +0.6% |
| Q1 2015 | $2,945,000 | -0.9% | 34,678 | +0.0% | 0.88% | -2.0% |
| Q4 2014 | $2,971,000 | +15.1% | 34,663 | +2.0% | 0.90% | +5.9% |
| Q3 2014 | $2,582,000 | -0.6% | 33,981 | +3.0% | 0.85% | +11.3% |
| Q2 2014 | $2,597,000 | +6.4% | 32,987 | +1.4% | 0.76% | +3.2% |
| Q1 2014 | $2,441,000 | -10.6% | 32,537 | -8.0% | 0.74% | -16.1% |
| Q4 2013 | $2,730,000 | +1.8% | 35,362 | -8.7% | 0.88% | -8.5% |
| Q3 2013 | $2,683,000 | +12.6% | 38,712 | +2.9% | 0.96% | +8.9% |
| Q2 2013 | $2,382,000 | – | 37,627 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |